HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gerald F Watts Selected Research

Acute Coronary Syndrome

1/2022Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study.
10/2021Exploring the association between stroke and acute myocardial infarction and statins adherence following a medicines co-payment increase.
1/2019Icosapent ethyl for dyslipidaemia in patients with diabetes and coronary artery disease: Act now to reduce it.
1/2017New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials.
11/2016Intensive LDL Reduction Post Acute Coronary Syndromes: A Catalyst for Improved Outcomes.
8/2013New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gerald F Watts Research Topics

Disease

136Cardiovascular Diseases (Cardiovascular Disease)
04/2024 - 02/2002
52Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
11/2023 - 03/2002
50Coronary Artery Disease (Coronary Atherosclerosis)
12/2023 - 01/2001
44Atherosclerosis
03/2024 - 05/2002
44Type 2 Diabetes Mellitus (MODY)
01/2023 - 12/2002
44Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2021 - 01/2003
43Dyslipidemias (Dyslipidemia)
11/2023 - 08/2002
35Insulin Resistance
01/2023 - 02/2002
30Coronary Disease (Coronary Heart Disease)
10/2023 - 02/2003
29Obesity
07/2022 - 05/2002
22Hypertension (High Blood Pressure)
07/2022 - 11/2002
20Abdominal Obesity
04/2016 - 02/2002
19Hypertriglyceridemia
02/2024 - 03/2006
19Hypercholesterolemia
11/2023 - 03/2002
16Weight Loss (Weight Reduction)
01/2022 - 02/2003
14Inflammation (Inflammations)
01/2024 - 07/2002
14Homozygous Familial Hypercholesterolemia
07/2023 - 08/2013
11Chronic Renal Insufficiency
01/2022 - 09/2009
10Myocardial Infarction
01/2022 - 03/2011
9Pancreatitis
04/2024 - 11/2013
8Aortic Valve Stenosis (Aortic Stenosis)
04/2024 - 05/2018
8Non-alcoholic Fatty Liver Disease
01/2017 - 02/2008
7Inborn Genetic Diseases (Disease, Hereditary)
01/2022 - 02/2015
7Psychotic Disorders (Schizoaffective Disorder)
01/2019 - 01/2013
7Overweight
12/2018 - 01/2003
6Diabetes Mellitus
01/2024 - 08/2012
6Acute Coronary Syndrome
01/2022 - 08/2013
6Stroke (Strokes)
10/2021 - 10/2004
6Hyperlipidemias (Hyperlipidemia)
11/2020 - 02/2003
5Muscular Diseases (Myopathy)
02/2023 - 02/2008
5Body Weight (Weight, Body)
08/2014 - 10/2009
4Alzheimer Disease (Alzheimer's Disease)
01/2024 - 01/2022
4Xanthomatosis (Xanthoma)
01/2018 - 12/2013
3Dementia (Dementias)
02/2024 - 01/2023

Drug/Important Bio-Agent (IBA)

77LDL CholesterolIBA
01/2024 - 02/2002
74Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2024 - 01/2001
67Lipoproteins (Lipoprotein)IBA
01/2023 - 02/2002
66LipidsIBA
03/2024 - 06/2002
65oxidized low density lipoproteinIBA
01/2024 - 02/2003
64Lipoprotein(a)IBA
04/2024 - 03/2014
62Triglycerides (Triacylglycerol)IBA
04/2024 - 02/2002
48CholesterolIBA
01/2024 - 03/2002
37LDL Lipoproteins (beta Lipoproteins)IBA
10/2023 - 03/2002
35HDL CholesterolIBA
02/2024 - 01/2001
29Apolipoproteins B (ApoB)IBA
01/2020 - 03/2002
28ApolipoproteinsIBA
11/2022 - 01/2004
25Apolipoprotein B-100 (Apo B 100)IBA
11/2021 - 02/2002
21Fenofibrate (CiL)FDA LinkGeneric
01/2021 - 12/2002
19Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
09/2023 - 11/2002
19Apolipoprotein A-I (Apolipoprotein A1)IBA
11/2021 - 03/2003
17Fibric Acids (Fibrates)IBA
03/2022 - 01/2001
17Insulin (Novolin)FDA Link
01/2019 - 08/2002
16HDL LipoproteinsIBA
11/2021 - 02/2004
15Apolipoprotein C-IIIIBA
02/2024 - 08/2002
13LDL Receptors (LDL Receptor)IBA
01/2023 - 03/2002
12Ezetimibe (Zetia)FDA Link
03/2022 - 05/2010
12Fish OilsIBA
11/2021 - 06/2002
11Atorvastatin (Lipitor)FDA Link
02/2023 - 05/2002
11IsotopesIBA
11/2021 - 05/2002
11VLDL LipoproteinsIBA
11/2021 - 01/2003
10CalciumIBA
01/2023 - 10/2018
10Apolipoprotein B-48IBA
12/2021 - 02/2003
10Fatty Acids (Saturated Fatty Acids)IBA
10/2016 - 12/2002
9AdiponectinIBA
09/2013 - 09/2004
8Niacin (Nicotinic Acid)FDA LinkGeneric
12/2016 - 01/2004
7C-Reactive ProteinIBA
01/2024 - 04/2002
7Apolipoproteins AIBA
03/2023 - 07/2005
7Blood Glucose (Blood Sugar)IBA
12/2018 - 06/2011
7ChylomicronsIBA
12/2016 - 02/2003
7Apolipoprotein A-II (Apolipoprotein A2)IBA
04/2016 - 07/2006
6Proteins (Proteins, Gene)FDA Link
01/2024 - 02/2004
6Apoprotein(a) (Apolipoprotein (a))IBA
03/2023 - 12/2010
6Proprotein Convertase 9IBA
03/2022 - 05/2016
6Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2018 - 05/2008
6coenzyme Q10 (CoQ10)IBA
01/2018 - 05/2003
6BMS201038IBA
07/2017 - 08/2013
6Interleukin-6 (Interleukin 6)IBA
05/2010 - 06/2002
5PCSK9 InhibitorsIBA
11/2023 - 08/2013
5Phytosterols (Plant Sterols)IBA
01/2023 - 02/2003
5Antihypertensive Agents (Antihypertensives)IBA
10/2017 - 08/2012
5Rosuvastatin Calcium (Crestor)FDA Link
06/2015 - 02/2008
5Cholesterol Ester Transfer ProteinsIBA
09/2009 - 12/2002
4Probucol (Lorelco)FDA Link
01/2024 - 01/2014
4Small Interfering RNA (siRNA)IBA
12/2023 - 01/2022
4Eicosapentaenoic AcidIBA
09/2023 - 11/2002
4Uric Acid (Urate)IBA
02/2023 - 06/2011
4Biomarkers (Surrogate Marker)IBA
01/2023 - 05/2017
4Apolipoproteins E (ApoE)IBA
11/2022 - 11/2012
4evolocumabIBA
01/2020 - 06/2014
4Glucose (Dextrose)FDA LinkGeneric
01/2019 - 03/2011
4Antipsychotic Agents (Antipsychotics)IBA
05/2016 - 06/2014
4Leucine (L-Leucine)FDA Link
10/2015 - 07/2006
4EnzymesIBA
09/2014 - 02/2004
4mipomersenIBA
08/2014 - 01/2012
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2005 - 07/2002
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2023 - 01/2006

Therapy/Procedure

72Therapeutics
03/2024 - 08/2002
16Drug Therapy (Chemotherapy)
10/2023 - 01/2004
14Blood Component Removal (Apheresis)
11/2022 - 08/2013
5Secondary Prevention
02/2021 - 01/2001